{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:25:57Z","timestamp":1793913957583,"version":"4.8.0"},"reference-count":3,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jtct.2026.10.004","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:17:27Z","timestamp":1792167447000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Does Less than 100\u202fmg\/kg Necessarily Represent Reduced Post-Transplant Cyclophosphamide Exposure?"],"prefix":"10.1016","author":[{"given":"Bohour","family":"AbdulMajeed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0325-4749","authenticated-orcid":false,"given":"Nahla","family":"Shihata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4426-9434","authenticated-orcid":false,"given":"Naif I.","family":"AlJohani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2026.10.004_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2026.08.003","article-title":"Reduced cumulative post-transplant cyclophosphamide exposure is associated with increased acute and chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation","author":"Soto","year":"2026","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2026.10.004_bib0002","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/s41409-026-02928-8","article-title":"Association of ideal body weight-normalized post-transplantation cyclophosphamide dose with chronic GVHD in patients with overweight\/obesity","volume":"61","author":"Nagano","year":"2026","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.10.004_bib0003","unstructured":"Blood and Marrow Transplant Clinical Trials Network. BMT CTN 1703 Protocol, Version 4.0. 2020. Accessed September 1, 2026. https:\/\/bmtctn.net\/system\/files\/BMT%20CTN%201703%20Protocol%20v4.0_CLEAN_0_0.pdf"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726007918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726007918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:50:30Z","timestamp":1793911830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726007918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":3,"alternative-id":["S2666636726007918"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.10.004","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does Less than 100\u202fmg\/kg Necessarily Represent Reduced Post-Transplant Cyclophosphamide Exposure?","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}